tiprankstipranks
Advertisement
Advertisement

EVH Stock Latest News

Evolent Health Shareholders Approve Proposals at 2026 Meeting
Company AnnouncementsEvolent Health Shareholders Approve Proposals at 2026 Meeting
7d ago
8K
EVH
Evolent Health price target raised to $5.50 from $4 at Citi
PremiumThe Fly
Evolent Health price target raised to $5.50 from $4 at Citi
27d ago
EVH
Evolent Health price target raised to $6 from $5 at Canaccord
PremiumThe Fly
Evolent Health price target raised to $6 from $5 at Canaccord
1M ago
EVH
Evolent Health Earnings Call Balances Growth and Risk
PremiumCompany Announcements
Evolent Health Earnings Call Balances Growth and Risk
1M ago
EVH
Evolent Health reports Q1 adjusted EPS (2c), consensus (5c)
PremiumThe Fly
Evolent Health reports Q1 adjusted EPS (2c), consensus (5c)
1M ago
EVH
Evolent Health appoints Archie Mayani as Chief Product Officer
PremiumThe FlyEvolent Health appoints Archie Mayani as Chief Product Officer
3M ago
EVH
Evolent Health price target lowered to $6 from $12 at Oppenheimer
Premium
The Fly
Evolent Health price target lowered to $6 from $12 at Oppenheimer
3M ago
EVH
Evolent Health: Conservative 2026 Guidance Masks Attractive Valuation and Upside to EBITDA Targets
Premium
Ratings
Evolent Health: Conservative 2026 Guidance Masks Attractive Valuation and Upside to EBITDA Targets
3M ago
EVH
Evolent Health Charts Growth Amid 2026 Margin Squeeze
PremiumCompany Announcements
Evolent Health Charts Growth Amid 2026 Margin Squeeze
3M ago
EVH
Evolent Health price target lowered to $5 from $10 at UBS
PremiumThe Fly
Evolent Health price target lowered to $5 from $10 at UBS
3M ago
EVH
Evolent Health price target lowered to $4 from $6 at Citi
PremiumThe Fly
Evolent Health price target lowered to $4 from $6 at Citi
4M ago
EVH
Evolent Health price target lowered to $6 from $10 at Truist
PremiumThe Fly
Evolent Health price target lowered to $6 from $10 at Truist
4M ago
EVH
Midday Fly By: Workday, Lowe’s in focus after earnings
PremiumThe FlyMidday Fly By: Workday, Lowe’s in focus after earnings
4M ago
DB
GS
Balancing Near-Term Execution Risk With Long-Term EBITDA Upside: Why Evolent Remains a Buy Despite a Lowered Target
Premium
Ratings
Balancing Near-Term Execution Risk With Long-Term EBITDA Upside: Why Evolent Remains a Buy Despite a Lowered Target
4M ago
EVH
Evolent Health price target lowered to $8 from $10 at BTIG
Premium
The Fly
Evolent Health price target lowered to $8 from $10 at BTIG
4M ago
EVH
Evolent Health price target lowered to $4 from $9 at Canaccord
PremiumThe Fly
Evolent Health price target lowered to $4 from $9 at Canaccord
4M ago
EVH
Evolent Health: Conservative Guidance and Elevated Reserves Set the Stage for 2026 Margin Upside and Support a Buy Rating
PremiumRatings
Evolent Health: Conservative Guidance and Elevated Reserves Set the Stage for 2026 Margin Upside and Support a Buy Rating
4M ago
EVH
Evolent Health downgraded to Sector Weight from Overweight at KeyBanc
PremiumThe Fly
Evolent Health downgraded to Sector Weight from Overweight at KeyBanc
4M ago
EVH
Evolent Health reports Q4 adjusted EPS 8c vs. (2c) last year
PremiumThe Fly
Evolent Health reports Q4 adjusted EPS 8c vs. (2c) last year
4M ago
EVH
Evolent Health sees FY26 revenue $2.4B-$2.6B, consensus $2.38B
PremiumThe FlyEvolent Health sees FY26 revenue $2.4B-$2.6B, consensus $2.38B
4M ago
EVH
EVH Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
EVH Upcoming Earnings Report: What to Expect?
4M ago
EVH
Evolent Health price target lowered to $10 from $16 at BTIG
Premium
The Fly
Evolent Health price target lowered to $10 from $16 at BTIG
4M ago
EVH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >